Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Decrease of hospital- and community-acquired bloodstream infections due to Streptococcus pneumoniae and Streptococcus pyogenes during the first year of the COVID-19 pandemic: A time-series analysis in Paris region.
Amarsy R, Fournier S, Trystram D, Monteil C, Raynaud X, Jarlier V, Robert J; la Collégiale de Bactériologie-Virologie-Hygiène de l'Assistance Publique-Hôpitaux de Paris. Amarsy R, et al. Am J Infect Control. 2023 Apr;51(4):475-477. doi: 10.1016/j.ajic.2022.09.002. Epub 2022 Sep 15. Am J Infect Control. 2023. PMID: 36115540 Free PMC article.
[Adjuvant surgical resection for multidrug-resistant tuberculosis: A review].
Mordant P, Henry B, Morel S, Robert J, Veziris N, Le Dû D, Frechet-Jachym M, Similowski T, Caumes É, Riquet M, Le Pimpec-Barthes F. Mordant P, et al. Among authors: veziris n. Rev Mal Respir. 2014 Jun;31(6):511-24. doi: 10.1016/j.rmr.2014.01.014. Epub 2014 Apr 18. Rev Mal Respir. 2014. PMID: 25012037 Review. French.
Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort.
Guglielmetti L, Le Dû D, Jachym M, Henry B, Martin D, Caumes E, Veziris N, Métivier N, Robert J; MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Cohort. Guglielmetti L, et al. Among authors: veziris n. Clin Infect Dis. 2015 Jan 15;60(2):188-94. doi: 10.1093/cid/ciu786. Epub 2014 Oct 15. Clin Infect Dis. 2015. PMID: 25320286
Management of emerging multidrug-resistant tuberculosis in a low-prevalence setting.
Catho G, Couraud S, Grard S, Bouaziz A, Sénéchal A, Valour F, Perpoint T, Braun E, Biron F, Ferry T, Chidiac C, Freymond N, Perrot E, Souquet PJ, Maury JM, Tronc F, Veziris N, Lina G, Dumitrescu O, Ader F; Lyon TB Study Group. Catho G, et al. Among authors: veziris n. Clin Microbiol Infect. 2015 May;21(5):472.e7-10. doi: 10.1016/j.cmi.2014.12.022. Epub 2015 Jan 20. Clin Microbiol Infect. 2015. PMID: 25708551 Free article.
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.
Lortholary O, Roussillon C, Boucherie C, Padoin C, Chaix ML, Breton G, Rami A, Veziris N, Patey O, Caumes E, May T, Molina JM, Robert J, Tod M, Fagard C, Chêne G; ANRS 129 BKVIR Trial Group. Lortholary O, et al. Among authors: veziris n. J Antimicrob Chemother. 2016 Mar;71(3):783-93. doi: 10.1093/jac/dkv384. Epub 2015 Dec 17. J Antimicrob Chemother. 2016. PMID: 26679250
174 results